Lou Gehrig’s Disease (ALS): UCSD Team’s Stem Cell Therapy Approach
(Part 2 of 8) Larry Goldstein, Ph.D. spoke at the "Spotlight on Disease Team Awards: ALS," an educational event presented at the CIRM Governing Board meeting on June 23, 2010. Goldstein is the principle investigator of the CIRM ALS Disease Team and director of the UC San Diego Stem Cell Program.
See the original post here:
Lou Gehrig's Disease (ALS): UCSD Team's Stem Cell Therapy Approach